chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Ureteral stent insertion, Urethral obstruction, Urinary retention, Vaccine breakthrough infection
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 2/9/21 (EL1283) Pfizer Dose 2 3/3/21 (EN6200) Pfizer Dose 3 10/16/21 (lot NA) COVID Positive 12/21/21 COVID Positive 12/24/21  12/13/21: Pt is an 83 year-old female with history of nonischemic cardiomyopathy, congestive heart failure, COPD, CKD IIIA, and proteus UTI approximately 1 year ago who presented to the ED this morning with acute right flank pain. Pt states she woke up with right flank pain radiating to her pubic bone at 1 am this morning and was unable to urinate. She then called her son who picked her up and brought her to the ED. Over this time, her pain increased significantly and was severely tachycardic in the 140s and tachypneic in the 40s in the emergency department. CBC revealed a leukocytosis of 16, ABG showed a metabolic acidosis, and abdominal CT showed an obstructing 8mm stone at the right UVJ. She received 2 gm ceftriaxone and 10 mg diltiazem in the ED.  Urology was consulted and the pt was taken to the OR for urgent stent placement of the right ureter. After the procedure, pt was hemodynamically stable and determined to be medically stable for admission to the medicine floor. Pt is currently feeling much better than this morning. She complains of low back pain and shortness of breath that are similar to her baseline. Daughter is requesting voltaren ointment for pt's arthritic low back pain. Pt has a history of tobacco and alcohol use with cessation approximately 1 year ago.  12/31/21: 83-year-old woman who presented with complaints of right flank pain and obstructive lower urinary tract symptoms.  In the emergency department she  was noted  to meet sepsis criteria with leukocytosis, tachycardic and hypertensive.  CT abdomen / pelvis demonstrated right ureteral calculus obstructing the right ureteropelvic junction.   Urology was emergently consulted and she underwent emergent cystoscopy with right ureteral stent placement following initiation of empiric antibiotic therapy.  Post procedural course was complicated by hypotension for which she was admitted to the intensive care unit for pressor support.  Blood cultures were subsequently positive for Proteus mirabilis for which she was appropriately treated with IV Zosyn.  She was also started on stress steroid  which is being tapered down to previous home dose.  Clinical response was favorable with resolution of leukocytosis, tachycardia and  hypotension.  COVID-19 PCR was subsequently noted to be positive during hospital course for which was treated with Decadron and remdesivir with good effect.  She was evaluated by Physical and Occupational therapy and recommended for further rehabilitation.  She has been discharged in stable medical condition to the acute rehab unit today.
Age: 53.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Blood creatine phosphokinase increased, Cellulitis, Hypoglycaemia, Hypotension, Injection site erythema
Clinical narrative: Tdap and Covid 19 booster in left arm 5/12/22. Patient reported left arm pain to his family and was found down by them 5/13/22. He was noted to have left arm swelling, erythema, hypotension, hypoglycemia with elevated CPK.  Diagnosis:  Secondary cellulitis of left UE extending to left chest wall 2/2 vaccinations.
Age: 53.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Tdap and Covid 19 booster in left arm 5/12/22. Patient reported left arm pain to his family and was found down by them 5/13/22. He was noted to have left arm swelling, erythema, hypotension, hypoglycemia with elevated CPK.  Diagnosis:  Secondary cellulitis of left UE extending to left chest wall 2/2 vaccinations.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Body temperature increased, Fatigue, Migraine, Muscle spasms
Clinical narrative: PATIENT EXPERIENCE RESTLESSNESS BEGINNING SHORTLY AFTER MIDNIGHT-ON & OFF AWAKENING THROUGHOUT THE EARLY MORNING HOURS. THIS MORNING WOKE UP WITH A MIGRAINE, TINGLING HANDS, LEG SPASMS, BACK PAIN, AND EXTREME FATIGUE IN SPITE OF TYLENOL DOSES.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Restlessness, Sleep disorder
Clinical narrative: PATIENT EXPERIENCE RESTLESSNESS BEGINNING SHORTLY AFTER MIDNIGHT-ON & OFF AWAKENING THROUGHOUT THE EARLY MORNING HOURS. THIS MORNING WOKE UP WITH A MIGRAINE, TINGLING HANDS, LEG SPASMS, BACK PAIN, AND EXTREME FATIGUE IN SPITE OF TYLENOL DOSES.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Headache, Myalgia, Pyrexia, Respiratory tract congestion
Clinical narrative: Covid break through case. Had lunch with a coworker on May 10 contact tested positive. I took extra precautions n95 mask and distanced myself from everybody friends co-works and family. Saturday afternoon allergy like symptoms itchy throat and that evening I also had major muscle aches. I went to bed early and had a restless night. Sunday was a bad day I tested positive on a Antigen At home test. Throughout Sunday they got worse muscles ache, headache, congestion was worse as well and fever was new. I took Tylenol and Advil at home on Sunday and it helped some but didn't fix everything.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Restlessness, SARS-CoV-2 test positive, Throat irritation, Vaccine breakthrough infection
Clinical narrative: Covid break through case. Had lunch with a coworker on May 10 contact tested positive. I took extra precautions n95 mask and distanced myself from everybody friends co-works and family. Saturday afternoon allergy like symptoms itchy throat and that evening I also had major muscle aches. I went to bed early and had a restless night. Sunday was a bad day I tested positive on a Antigen At home test. Throughout Sunday they got worse muscles ache, headache, congestion was worse as well and fever was new. I took Tylenol and Advil at home on Sunday and it helped some but didn't fix everything.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Confusional state, Fall, Laboratory test normal
Clinical narrative: Patient began having confusion and worsening weakness into the evening.  This resulted in 2 falls at home.  Went to hospital.  Work up for infection showed no results.  Patient gradually improved over 3 days in hospital.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Blood creatinine increased, Blood gases, COVID-19, Carbon dioxide increased, Chest X-ray abnormal
Clinical narrative: COVId Vaccine Breakthrough Case  Pfizer Dose 1 5/4/21 (ER8736) Pfizer Dose 2 5/26/21 (EW0168) COVID Positive 12/7/21  12/7/21: Patient 64-year-old female with history of CKD stage 4, diabetes mellitus, obesity, hyperlipidemia, hypertension, no history of asthma or COPD however uses inhaler as needed she does not know why, no history of obstructive sleep apnea, received COVID-19 vaccine in April, presenting to the emergency department with a complaint of worsening shortness of breath of couple of days duration.  Associated with cough and sputum production, denies any fever or chills, reports worsening shortness of breath, reports close contact with COVID-19 positive friend, she also reports lower extremity edema for which she takes torsemide however denies heart failure.   In ED, upon arrival O2 saturation 89% on room air, was placed on 2 L and escalated to 5 L upon my exam.  Chest x-ray suggestive bilateral pneumonia, was given Rocephin and Zithromax.  Creatinine 2.3 and seems to be at baseline, troponin 0.04 with no chest pain, blood gas showed CO2 retention, ED provider requesting admission.  12/30/21: care coordination intervention for oxygen/ home medical equipment ordered and delivery  Continue steroid taper as ordered,  continue other home medications  Stable for discharge home today with home  health services and program.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Exposure to SARS-CoV-2, Hypercapnia, Inappropriate schedule of product administration
Clinical narrative: COVId Vaccine Breakthrough Case  Pfizer Dose 1 5/4/21 (ER8736) Pfizer Dose 2 5/26/21 (EW0168) COVID Positive 12/7/21  12/7/21: Patient 64-year-old female with history of CKD stage 4, diabetes mellitus, obesity, hyperlipidemia, hypertension, no history of asthma or COPD however uses inhaler as needed she does not know why, no history of obstructive sleep apnea, received COVID-19 vaccine in April, presenting to the emergency department with a complaint of worsening shortness of breath of couple of days duration.  Associated with cough and sputum production, denies any fever or chills, reports worsening shortness of breath, reports close contact with COVID-19 positive friend, she also reports lower extremity edema for which she takes torsemide however denies heart failure.   In ED, upon arrival O2 saturation 89% on room air, was placed on 2 L and escalated to 5 L upon my exam.  Chest x-ray suggestive bilateral pneumonia, was given Rocephin and Zithromax.  Creatinine 2.3 and seems to be at baseline, troponin 0.04 with no chest pain, blood gas showed CO2 retention, ED provider requesting admission.  12/30/21: care coordination intervention for oxygen/ home medical equipment ordered and delivery  Continue steroid taper as ordered,  continue other home medications  Stable for discharge home today with home  health services and program.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Oedema peripheral, Pneumonia, Productive cough, SARS-CoV-2 test positive, Troponin
Clinical narrative: COVId Vaccine Breakthrough Case  Pfizer Dose 1 5/4/21 (ER8736) Pfizer Dose 2 5/26/21 (EW0168) COVID Positive 12/7/21  12/7/21: Patient 64-year-old female with history of CKD stage 4, diabetes mellitus, obesity, hyperlipidemia, hypertension, no history of asthma or COPD however uses inhaler as needed she does not know why, no history of obstructive sleep apnea, received COVID-19 vaccine in April, presenting to the emergency department with a complaint of worsening shortness of breath of couple of days duration.  Associated with cough and sputum production, denies any fever or chills, reports worsening shortness of breath, reports close contact with COVID-19 positive friend, she also reports lower extremity edema for which she takes torsemide however denies heart failure.   In ED, upon arrival O2 saturation 89% on room air, was placed on 2 L and escalated to 5 L upon my exam.  Chest x-ray suggestive bilateral pneumonia, was given Rocephin and Zithromax.  Creatinine 2.3 and seems to be at baseline, troponin 0.04 with no chest pain, blood gas showed CO2 retention, ED provider requesting admission.  12/30/21: care coordination intervention for oxygen/ home medical equipment ordered and delivery  Continue steroid taper as ordered,  continue other home medications  Stable for discharge home today with home  health services and program.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: COVId Vaccine Breakthrough Case  Pfizer Dose 1 5/4/21 (ER8736) Pfizer Dose 2 5/26/21 (EW0168) COVID Positive 12/7/21  12/7/21: Patient 64-year-old female with history of CKD stage 4, diabetes mellitus, obesity, hyperlipidemia, hypertension, no history of asthma or COPD however uses inhaler as needed she does not know why, no history of obstructive sleep apnea, received COVID-19 vaccine in April, presenting to the emergency department with a complaint of worsening shortness of breath of couple of days duration.  Associated with cough and sputum production, denies any fever or chills, reports worsening shortness of breath, reports close contact with COVID-19 positive friend, she also reports lower extremity edema for which she takes torsemide however denies heart failure.   In ED, upon arrival O2 saturation 89% on room air, was placed on 2 L and escalated to 5 L upon my exam.  Chest x-ray suggestive bilateral pneumonia, was given Rocephin and Zithromax.  Creatinine 2.3 and seems to be at baseline, troponin 0.04 with no chest pain, blood gas showed CO2 retention, ED provider requesting admission.  12/30/21: care coordination intervention for oxygen/ home medical equipment ordered and delivery  Continue steroid taper as ordered,  continue other home medications  Stable for discharge home today with home  health services and program.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: One day prior to the clinic on 5/18/22, an email was sent to the pharmacy with a list of patients that needed boosters. At the start of the clinic on 5/19/22, copies of vaccine cards for these patients were given to the pharmacy staff. All cards were checked by the pharmacy to ensure eligibility for boosters. Vaccine administration started at 1pm. At approximately 1:20pm, after 14 vaccines were given, the pharmacy was alerted that the copies of vaccine cards and emailed list were not up-to-date. After consulting with the person, who had an updated list of vaccine records, it was determined that six patients were given a booster shot when not eligible. Consulted with the pharmacy team on how to follow-up and proceed with the clinic. Going forward, each patient vaccinated had their records verified on the system and online. Emailed list was cross-checked with the updated list given. Even with updated list from facility, errors were found with vaccine records not being up-to-date and inconsistencies. Photos of covid vaccination cards were taken for records and vaccination cards were sorted.  Patient rccieved second booster but did not qualify for second booster.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 11.0
Sex: M
Vaccine: TDAP
Symptoms: Injection site bruising, Vaccination site erythema, Vaccination site nodule, Vaccination site swelling
Clinical narrative: Pt had a 6 cm  in diameter area of swelling and redness to arm where vaccine was given. Also with a knot under the skin and a small bruise at the injection site.  Dad called our office 4 days afterwards asking if we would look at it as he was concerned. He brought pt to our office.  I advised him to use Ibuprofen for pain, take a Benadryl before bedtime for redness/swelling, and apply a cold compress to it. Dad verbalized understanding.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State  for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: The wife of the person reported that he was admitted to hospital after complaining headache
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: When our facility received the Covid - 19 vaccine, I spoke to a health professional and was told that the exp. date for the vaccine was 9 months from the mfg. date on the box. Which made the exp. date 5/31/22. On 5/20/22 Health Professional Contacted me stating that we have given exp. vaccines to patients and that the exp. date was 10 weeks from the date the vaccine was received which would have been 5/2/22. Thus, we unknowingly gave exp vaccine to patient.   Patient tolerated vaccine well, no adverse effects have been reported.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: NO ADVERSE REACYTION WHATSOEVER!!  JUST GOT SLIGHTLY EXPIRED VACCINE
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Circumstance or information capable of leading to medication error, Extra dose administered, Product administered to patient of inappropriate age
Clinical narrative: One day prior to the clinic on 5/18/22, an email was sent with a list of patients that needed boosters. At the start of the clinic on 5/19/22, copies of vaccine cards for these patients were given to staff. All cards were checked by ensure eligibility for boosters. Vaccine administration started at 1pm. At approximately 1:20pm, after 14 vaccines were given, staff alerted facility that the copies of vaccine cards and emailed list were not up-to-date. After consulting with staff, who had an updated list of vaccine records, it was determined that six patients were given a booster shot when not eligible. Consulted with facility team on how to follow-up and proceed with the clinic. Going forward, each patient vaccinated had their records verified on the databases. Emailed list was cross-checked with the updated list given by staff. Even with updated list from facility, errors were found with vaccine records not being up-to-date and inconsistencies. Photos of covid vaccination cards were taken for records and vaccination cards were sorted.  Patient recieved second booster but did not qualify for second booster.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Chest X-ray, Depression, Dysuria, Gait disturbance
Clinical narrative: He was in the ER for depression, and while he was there he received the vaccine as they informed him he could not go places without a vaccine card so decided to get it.   After the vaccine he had pain in his back, wasn't too sure if it was in his back or legs.  He was diagnosed with lower back sciatica.  He went to his PCP for his pain and she referred him to a neurologist, pulmonary vasculature.  He was diagnosed with MS but are awaiting to get an MRI to rule out that diagnosis.  He had an x-ray for a TB test, which showed pulmonary vasculature and they suggested the MRI, and is waiting to get that done which is scheduled on 6/22/22.    He has a hard time walking, and has a hard time urinating whether it's bladder or kidneys but will be determined once he gets the MRI.  He will then perhaps to see a neurologist.  He did not have these symptoms prior to the vaccine.    His records indicate that he is diagnosed with an undiagnosed STD from about 7 years ago and feels that this may be something to do with the chain reaction of events that he has had in his life.  He is going to be going to a disease specialist to see about this.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Multiple sclerosis, Mycobacterium tuberculosis complex test, Pulmonary vascular disorder, Sciatica, X-ray
Clinical narrative: He was in the ER for depression, and while he was there he received the vaccine as they informed him he could not go places without a vaccine card so decided to get it.   After the vaccine he had pain in his back, wasn't too sure if it was in his back or legs.  He was diagnosed with lower back sciatica.  He went to his PCP for his pain and she referred him to a neurologist, pulmonary vasculature.  He was diagnosed with MS but are awaiting to get an MRI to rule out that diagnosis.  He had an x-ray for a TB test, which showed pulmonary vasculature and they suggested the MRI, and is waiting to get that done which is scheduled on 6/22/22.    He has a hard time walking, and has a hard time urinating whether it's bladder or kidneys but will be determined once he gets the MRI.  He will then perhaps to see a neurologist.  He did not have these symptoms prior to the vaccine.    His records indicate that he is diagnosed with an undiagnosed STD from about 7 years ago and feels that this may be something to do with the chain reaction of events that he has had in his life.  He is going to be going to a disease specialist to see about this.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Immediate post-injection reaction, Injected limb mobility decreased, Injection site pain
Clinical narrative: Immediately after the injection I had pain where the shot was administered and thought that it would go away in a couple of days. The next day I woke up with more paid and limited movement of my left arm. Hoping that this was temporary I fought through the pain and tried excercising and stretching; which had no releif. I have been living with this svere pain and limted use of my left arm so I visited my family doctor and he had never heard of this before and told me to get an MRI.
Age: 50.0
Sex: F
Vaccine: HEP
Symptoms: Dizziness, Flushing, Presyncope
Clinical narrative: Pt felt faint and flushed and had a vasovagal response after vaccine. Pt was assisted to ground where she quickly came to and was able to communicate. Pt was given an ice pack and water. Pt got up from the ground and sat in chair for about 10minutes then left on own accord. Called patient one hour later to check on her, and she appreciated the call and said she felt fine.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: When our facility received the Covid - 19 vaccine, I spoke with Dept. of Health and was told that the exp. date for the vaccine was 9 months from the mfg. date on the box. Which made the exp. date 5/31/22. On 5/20/22  at the Dept. of Health contacted me stating that we have given exp. vaccines to patients and that the exp. date was 10 weeks from the date the vaccine was received which would have been 4/29/22. Thus, we unknowingly gave exp. vaccine to patient.  Patient tolerated vaccine well, no adverse effects have been reported.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: NO ADVERSE REACTKION WHATSOEVER...  JUST REPORTING THAT ;PATIENT GOT A BIT EXPIRED VACCINE
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation error
Clinical narrative: 0.2ml of undiluted (not reconstituted) Pfizer Covid 5-11 yr olds vaccine administered to patient for her "booster"
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Exposure to SARS-CoV-2, Head discomfort, Headache
Clinical narrative: Breakthrough COVID-19 case: I was exposed so I decided to test for COVID-19 on 05/16/2022 and the test came back positive. I did not experience symptoms until the following day. I developed a headache and a stuffy head, like a pressure feeling. I also started to have an upper sore throat. I experienced a stuffy nose. There was no drainage. I didn't really experience a cough, but if I did have one large cough I would expel a big sticky mucus discharge. I contacted my doctor and they told me I was qualified for their COVID-19 clinic and was prescribed Paxlovid. I started it yesterday and it seems to be helping. I only coughed once today and my sore throat seems to be getting better.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Oropharyngeal pain, SARS-CoV-2 test positive, Secretion discharge, Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID-19 case: I was exposed so I decided to test for COVID-19 on 05/16/2022 and the test came back positive. I did not experience symptoms until the following day. I developed a headache and a stuffy head, like a pressure feeling. I also started to have an upper sore throat. I experienced a stuffy nose. There was no drainage. I didn't really experience a cough, but if I did have one large cough I would expel a big sticky mucus discharge. I contacted my doctor and they told me I was qualified for their COVID-19 clinic and was prescribed Paxlovid. I started it yesterday and it seems to be helping. I only coughed once today and my sore throat seems to be getting better.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: When our facility received the Covid - 19 vaccine, I spoke at Dept of Health and was told that the exp. date for the vaccine was 9 months from the mfg. date on the box. Which made the exp. date 5/31/22. On 5/20/22 the Dept of Health Contacted me stating that we have given exp. vaccines to patients and that the exp. date was 10 weeks from the date the vaccine was received which would have been 4/29/22. Thus, we unknowingly gave exp vaccine to patient.   Patient tolerated vaccine well, no adverse effects have been reported.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Oropharyngeal pain, Pain, SARS-CoV-2 test positive
Clinical narrative: Positive COVID 19, fatigue, sore throat and aches and pains.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Choking, Dizziness, Impaired driving ability, Injection site pain
Clinical narrative: Every night I was having difficulty sleeping waking up choking. And when I was sleeping I was awake. I was having such difficultly sleeping that I was nodding off while driving. And doctor ordered a sleep study. I was diagnosed with sleep apnea. I had no symptoms the month prior to having COVID and then started having difficulty sleeping. I let it go on for a while before going to the doctor. I also had adverse reaction to the injection site being painful and the swelling went under my arm to my breast muscle and I couldn't lift it for 2 days. I had a 101-103 fever for 2 days. The 3rd morning I was regular temperature. Besides the nausea and dizziness that was about all the reaction.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Insomnia, Nausea, Pyrexia, Sleep apnoea syndrome
Clinical narrative: Every night I was having difficulty sleeping waking up choking. And when I was sleeping I was awake. I was having such difficultly sleeping that I was nodding off while driving. And doctor ordered a sleep study. I was diagnosed with sleep apnea. I had no symptoms the month prior to having COVID and then started having difficulty sleeping. I let it go on for a while before going to the doctor. I also had adverse reaction to the injection site being painful and the swelling went under my arm to my breast muscle and I couldn't lift it for 2 days. I had a 101-103 fever for 2 days. The 3rd morning I was regular temperature. Besides the nausea and dizziness that was about all the reaction.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep study abnormal, Swelling
Clinical narrative: Every night I was having difficulty sleeping waking up choking. And when I was sleeping I was awake. I was having such difficultly sleeping that I was nodding off while driving. And doctor ordered a sleep study. I was diagnosed with sleep apnea. I had no symptoms the month prior to having COVID and then started having difficulty sleeping. I let it go on for a while before going to the doctor. I also had adverse reaction to the injection site being painful and the swelling went under my arm to my breast muscle and I couldn't lift it for 2 days. I had a 101-103 fever for 2 days. The 3rd morning I was regular temperature. Besides the nausea and dizziness that was about all the reaction.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Malaise, Nasal congestion, Pain
Clinical narrative: On the 14th I thought I was getting a sinus infection and had a low grade fever. I was really stuffy, I couldn't breath, I had pain and sinus pressure, and it couldn't breath. By Monday my symptoms were worse so I tested on a home test and was positive. I reached out to my PCP and they got me a cough med, an antibiotic, and prednisone. Today is the first day I am really feeling good but Wednesday this week the 18th was the first day I had started improving.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Paranasal sinus discomfort, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: On the 14th I thought I was getting a sinus infection and had a low grade fever. I was really stuffy, I couldn't breath, I had pain and sinus pressure, and it couldn't breath. By Monday my symptoms were worse so I tested on a home test and was positive. I reached out to my PCP and they got me a cough med, an antibiotic, and prednisone. Today is the first day I am really feeling good but Wednesday this week the 18th was the first day I had started improving.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: When our facility received the Covid - 19 vaccine, I spoke and was told that the exp. date for the vaccine was 9 months from the. date on the box. Which made the exp. date 5/31/22. On 5/20/22 Contacted me stating that we have given exp. vaccines to patients and that the exp. date was 10 weeks from the date the vaccine was received which would have been 5/2/22. Thus we unknowingly gave exp vaccine to patient.   Patient tolerated vaccine well, no adverse effects have been reported.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Circumstance or information capable of leading to medication error, Extra dose administered, Product administered to patient of inappropriate age
Clinical narrative: One day prior to the clinic on 5/18/22, an email was sent to the pharmacy with a list of patients that needed boosters. At the start of the clinic on 5/19/22, copies of vaccine cards for these patients were given to the pharmacy staff. All cards were checked by the pharmacy to ensure eligibility for boosters. Vaccine administration started at 1pm. At approximately 1:20pm, after 14 vaccines were given, a person alerted the pharmacy that the copies of vaccine cards and emailed list were not up-to-date. After consulting with the person, who had an updated list of vaccine records, it was determined that six patients were given a booster shot when not eligible. Consulted with the pharmacy team on how to follow-up and proceed with the clinic. Going forward, each patient vaccinated had their records verified on the system and online. Emailed list was cross-checked with the updated list. Even with updated list from facility, errors were found with vaccine records not being up-to-date and inconsistencies. Photos of covid vaccination cards were taken for records and vaccination cards were sorted.  Patient recieved second booster but did not qualify for second booster.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Laboratory test
Clinical narrative: Patient experienced rapid heart rate, high enough she sought medical attention at an emergency dept the day following her covid immunization. After a round of tests, provider informed patient it was likely a reaction to the covid immunization she received.  Symptoms have resolved since then.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccines where not stored at correct temperature they had been stored in freezer instead of refrigerator.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: When our facility received the COVID - 19 vaccine, I spoke to the Dept. of Health and was told that the exp. date for the vaccine was 9 months from the mfg. date on the box. Which made the exp. date 5/31/22. On 5/20/22 at the  Dept. of Health contacted me stating that we have given exp. vaccines to patients and that the exp. date was 10 weeks from the date the vaccine was received which would have been 5/2/22. Thus we unknowingly gave exp. vaccine to patient.  Patient tolerated vaccine well, no adverse effects have been reported.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination error
Clinical narrative: One day prior to the clinic on 5/18/22, an email was sent with a list of patients that needed boosters. At the start of the clinic on 5/19/22, copies of vaccine cards for these patients were given to staff. All cards were checked to ensure eligibility for boosters. Vaccine administration started at 1pm. At approximately 1:20pm, after 14 vaccines were given, alerted that the copies of vaccine cards and emailed list were not up-to-date. After consulting who had an updated list of vaccine records, it was determined that six patients were given a booster shot when not eligible. Consulted with team on how to follow-up and proceed with the clinic. Going forward, each patient vaccinated had their records verified. Emailed list was cross-checked with the updated list given. Even with updated list from facility, errors were found with vaccine records not being up-to-date and inconsistencies. Photos of COVID vaccination cards were taken for records and vaccination cards were sorted.  Patient received second booster but did not qualify for second booster.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: When our facility received the Covid - 19 vaccine, I spoke to staff at the local Dept of Health and was told that the exp. date for the vaccine was 9 months from the mfg. date on the box. Which made the exp. date 5/31/22. On 5/20/22 staff at the local Dept of Health Contacted me stating that we have given exp. vaccines to patients and that the exp. date was 10 weeks from the date the vaccine was received which would have been 5/2/22. Thus we unknowingly gave exp vaccine to patient.   Patient tolerated vaccine well, no adverse effects have been reported.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Faecal disimpaction, Gastrointestinal disorder, Intestinal obstruction, Treatment failure, Urinary tract infection
Clinical narrative: Hospitalization for uti and colon problems. UTI failed outpatient treatment. ER disimpacted colon.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Ear discomfort, Feeling abnormal, Headache
Clinical narrative: 5/13 Sore throat and coughing started. 5/14 Sore throat and very bad cough. Fever 100.6, ears and head felt fuzzy, took Tylenol and Tussin DM to treat symptoms. Fever lasted all day. 5/15 No fever, but symptoms continued otherwise. 5/16, No fever, but cough improved, though sounded wet. All other symptoms same. 5/17 No change in symptoms. Took at home Covid test, which was positive. 5/18 Headache all day, metallic taste in mouth. 5/19 No change. 5/20 produced dark yellow sputum.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test normal, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test positive, Sputum discoloured
Clinical narrative: 5/13 Sore throat and coughing started. 5/14 Sore throat and very bad cough. Fever 100.6, ears and head felt fuzzy, took Tylenol and Tussin DM to treat symptoms. Fever lasted all day. 5/15 No fever, but symptoms continued otherwise. 5/16, No fever, but cough improved, though sounded wet. All other symptoms same. 5/17 No change in symptoms. Took at home Covid test, which was positive. 5/18 Headache all day, metallic taste in mouth. 5/19 No change. 5/20 produced dark yellow sputum.
Age: 6.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: When our facility received the COVID - 19 vaccine, I spoke to Dept. of Health and was told that the exp. date for the vaccine was 9 months from the mfg. date on the box. Which made the exp. date 5/31/22. On 5/20/22 at the  Dept. of Health contacted me stating that we have given exp. vaccines to patients and that the exp. date was 10 weeks from the date the vaccine was received which would have been 5/2/22. Thus we unknowingly gave exp. vaccine to patient. Patient tolerated vaccine well, no adverse effects have been reported.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Circumstance or information capable of leading to medication error, Extra dose administered, Product administered to patient of inappropriate age
Clinical narrative: One day prior to the clinic on 5/18/22, an email was sent to the pharmacy with a list of patients that needed boosters. At the start of the clinic on 5/19/22, copies of vaccine cards for these patients were given to the pharmacy staff. All cards were checked by the pharmacy to ensure eligibility for boosters. Vaccine administration started at 1pm. At approximately 1:20pm, after 14 vaccines were given, a person alerted the pharmacy that the copies of vaccine cards and emailed list were not up-to-date. After consulting with that person who had an updated list of vaccine records, it was determined that six patients were given a booster shot when not eligible. Consulted with the pharmacy team on how to follow-up and proceed with the clinic. Going forward, each patient vaccinated had their records verified on the system and online. Emailed list was cross-checked with the updated list. Even with updated list from facility, errors were found with vaccine records not being up-to-date and inconsistencies. Photos of covid vaccination cards were taken for records and vaccination cards were sorted.  Patient recieved second booster but did not qualify for second booster.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, COVID-19, Headache, Paranasal sinus discomfort, SARS-CoV-2 test positive
Clinical narrative: Starting 05/11/2022, I developed a headache, achy joints and sinus pressure. So, we decided to get tested on 05/13/2022 and it came back positive. They told us to go home and quarantine for 5 days, and we were told to take ibuprofen or Tylenol as needed. Its been a week to this day and I still have sinus pressure.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccines where not stored at correct temperature they had been stored in freezer instead of refrigerator
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: When our facility received the Covid - 19 vaccine, was told that the exp. date for the vaccine was 9 months from  date on the box. Which made the exp. date 5/31/22. On 5/20/22 Contacted me stating that we have given exp. vaccines to patients and that the exp. date was 10 weeks from the date the vaccine was received which would have been 5/2/22. Thus we unknowingly gave exp vaccine to patient.   Patient tolerated vaccine well, no adverse effects have been reported.